A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)
Clinical trial NCT02417597 · COMPLETED
Trial details
- NCT number
- NCT02417597
- Sponsor
- Xiamen Innovax Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-05-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.